-
1
-
-
79955415674
-
A receptors
-
A receptors. Bioorg Med Chem 2011; 19: 2927-38.
-
(2011)
Bioorg Med Chem
, vol.19
, pp. 2927-2938
-
-
Alhambra, C.1
Becker, C.2
Blake, T.3
Chang, A.H.4
Damewood Jr., J.R.5
Daniels, T.6
Dembofsky, B.T.7
Gurley, D.A.8
Hall, J.E.9
Herzog, K.J.10
Horchler, C.L.11
Ohnmacht, C.J.12
Schmiesing, R.J.13
Dudley, A.14
Ribadeneira, M.D.15
Knappenberger, K.S.16
Maciag, C.17
Stein, M.M.18
Chopra, M.19
Liu, X.F.20
Christian, E.P.21
Arriza, J.L.22
Chapdelaine, M.J.23
more..
-
3
-
-
33745122547
-
A receptors: subtypes, regional distribution, and function
-
A receptors: subtypes, regional distribution, and function. J Clin Sleep Med 2006; 2: S7-11.
-
(2006)
J Clin Sleep Med
, vol.2
-
-
Nutt, D.1
-
4
-
-
34247842810
-
Current approaches to the pharmacologic treatment of anxiety disorders
-
Sheehan DV, Sheehan KH. Current approaches to the pharmacologic treatment of anxiety disorders. Psychopharmacol Bull 2007; 40: 98-109.
-
(2007)
Psychopharmacol Bull
, vol.40
, pp. 98-109
-
-
Sheehan, D.V.1
Sheehan, K.H.2
-
5
-
-
30844463216
-
Glutamate- and GABA-based CNS therapeutics
-
Foster AC, Kemp JA. Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol 2006; 6: 7-17.
-
(2006)
Curr Opin Pharmacol
, vol.6
, pp. 7-17
-
-
Foster, A.C.1
Kemp, J.A.2
-
6
-
-
12344331438
-
A receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs
-
A receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr 2005; 10: 40-8.
-
(2005)
CNS Spectr
, vol.10
, pp. 40-48
-
-
Rowlett, J.K.1
Cook, J.M.2
Duke, A.N.3
Platt, D.M.4
-
7
-
-
0032924934
-
Cytochrome P-450 3A4: regulation and role in drug metabolism
-
Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999; 39: 1-17.
-
(1999)
Annu Rev Pharmacol Toxicol
, vol.39
, pp. 1-17
-
-
Guengerich, F.P.1
-
8
-
-
66449111462
-
Insights into the structure, function, and regulation of human cytochrome P450 1A2
-
Zhou SF, Chan E, Zhou ZW, Xue CC, Lai X, Duan W. Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr Drug Metab 2009; 10: 713-29.
-
(2009)
Curr Drug Metab
, vol.10
, pp. 713-729
-
-
Zhou, S.F.1
Chan, E.2
Zhou, Z.W.3
Xue, C.C.4
Lai, X.5
Duan, W.6
-
9
-
-
67649404709
-
In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective
-
Chu V, Einolf HJ, Evers R, Kumar G, Moore D, Ripp S, Silva J, Sinha V, Sinz M, Skerjanec A. In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective. Drug Metab Dispos 2009; 37: 1339-54.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1339-1354
-
-
Chu, V.1
Einolf, H.J.2
Evers, R.3
Kumar, G.4
Moore, D.5
Ripp, S.6
Silva, J.7
Sinha, V.8
Sinz, M.9
Skerjanec, A.10
-
10
-
-
0036515846
-
Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man
-
Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 2002; 32: 165-206.
-
(2002)
Xenobiotica
, vol.32
, pp. 165-206
-
-
Gibson, G.G.1
Plant, N.J.2
Swales, K.E.3
Ayrton, A.4
El-Sankary, W.5
-
11
-
-
1642498178
-
Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor
-
Chen Y, Ferguson SS, Negishi M, Goldstein JA. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther 2004; 308: 495-501.
-
(2004)
J Pharmacol Exp Ther
, vol.308
, pp. 495-501
-
-
Chen, Y.1
Ferguson, S.S.2
Negishi, M.3
Goldstein, J.A.4
-
12
-
-
0038768712
-
Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals
-
Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003; 43: 309-34.
-
(2003)
Annu Rev Pharmacol Toxicol
, vol.43
, pp. 309-334
-
-
Denison, M.S.1
Nagy, S.R.2
-
13
-
-
0034964158
-
Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation
-
LeCluyse EL. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 2001; 13: 343-68.
-
(2001)
Eur J Pharm Sci
, vol.13
, pp. 343-368
-
-
LeCluyse, E.L.1
-
14
-
-
46449089949
-
Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies
-
Kanebratt KP, Andersson TB. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos 2008; 36: 1444-52.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1444-1452
-
-
Kanebratt, K.P.1
Andersson, T.B.2
-
15
-
-
1642498315
-
Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible
-
Stresser DM, Broudy MI, Ho T, Cargill CE, Blanchard AP, Sharma R, Dandeneau AA, Goodwin JJ, Turner SD, Erve JC, Patten CJ, Dehal SS, Crespi CL. Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible. Drug Metab Dispos 2004; 32: 105-12.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 105-112
-
-
Stresser, D.M.1
Broudy, M.I.2
Ho, T.3
Cargill, C.E.4
Blanchard, A.P.5
Sharma, R.6
Dandeneau, A.A.7
Goodwin, J.J.8
Turner, S.D.9
Erve, J.C.10
Patten, C.J.11
Dehal, S.S.12
Crespi, C.L.13
-
16
-
-
66649089506
-
Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells
-
McGinnity DF, Zhang G, Kenny JR, Hamilton GA, Otmani S, Stams KR, Haney S, Brassil P, Stresser DM, Riley RJ. Evaluation of multiple in vitro systems for assessment of CYP3A4 induction in drug discovery: human hepatocytes, pregnane X receptor reporter gene, and Fa2N-4 and HepaRG cells. Drug Metab Dispos 2009; 37: 1259-68.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1259-1268
-
-
McGinnity, D.F.1
Zhang, G.2
Kenny, J.R.3
Hamilton, G.A.4
Otmani, S.5
Stams, K.R.6
Haney, S.7
Brassil, P.8
Stresser, D.M.9
Riley, R.J.10
-
17
-
-
33846577441
-
Drug interaction studies: study design, data analysis, and implications for dosing and labeling
-
Huang SM, Temple R, Throckmorton DC, Lesko LJ. Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clin Pharmacol Ther 2007; 81: 298-304.
-
(2007)
Clin Pharmacol Ther
, vol.81
, pp. 298-304
-
-
Huang, S.M.1
Temple, R.2
Throckmorton, D.C.3
Lesko, L.J.4
-
18
-
-
34247394165
-
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models
-
Vossen M, Sevestre M, Niederalt C, Jang IJ, Willmann S, Edginton AN. Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models. Theor Biol Med Model 2007; 26: 4-13.
-
(2007)
Theor Biol Med Model
, vol.26
, pp. 4-13
-
-
Vossen, M.1
Sevestre, M.2
Niederalt, C.3
Jang, I.J.4
Willmann, S.5
Edginton, A.N.6
-
19
-
-
51649119903
-
Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping
-
Link B, Haschke M, Grignaschi N, Bodmer M, Aschmann YZ, Wenk M, Krähenbühl S. Pharmacokinetics of intravenous and oral midazolam in plasma and saliva in humans: usefulness of saliva as matrix for CYP3A phenotyping. Br J Clin Pharmacol 2008; 66: 473-84.
-
(2008)
Br J Clin Pharmacol
, vol.66
, pp. 473-484
-
-
Link, B.1
Haschke, M.2
Grignaschi, N.3
Bodmer, M.4
Aschmann, Y.Z.5
Wenk, M.6
Krähenbühl, S.7
-
20
-
-
77958498196
-
Evaluation of models for predicting drug-drug interactions due to induction
-
Fahmi OA, Ripp SL. Evaluation of models for predicting drug-drug interactions due to induction. Expert Opin Drug Metab Toxicol 2010; 6: 1399-416.
-
(2010)
Expert Opin Drug Metab Toxicol
, vol.6
, pp. 1399-1416
-
-
Fahmi, O.A.1
Ripp, S.L.2
|